The synthesis of a carotenoporphyrin-quinone triad in which electron donor and acceptor moieties are covalently linked to superstructures of a photochemically active basket-handle porphyrin is described and its characterization by 1H NMR and UV - visible spectroscopy is reported. Under light excitation of this compound, when incorporated into a phospholipid bilayer membrane and in the presence of redox
描述了其中电子供体和受体部分与光化学活性篮柄式卟啉的超结构共价连接的胡萝卜素卟啉-醌三联体的合成方法,并报道了其通过1 H NMR和UV-可见光谱的表征。在该化合物的光激发下,当掺入磷脂双层膜中并且在氧化膜存在的水相中存在氧化膜化合物时,观察到稳态光电流,这意味着电荷分离。
[EN] ACTIVATABLE PHOTODYNAMIC THERAPY AGENTS<br/>[FR] AGENTS DE THERAPIE PHOTODYNAMIQUE ACTIVABLES
申请人:UNIV PENNSYLVANIA
公开号:WO2005048944A3
公开(公告)日:2006-05-04
Simultaneous Electrochemical and Electron Paramagnetic Resonance Studies of Carotenoids: Effect of Electron Donating and Accepting Substituents
作者:A. S. Jeevarajan、M. Khaled、L. D. Kispert
DOI:10.1021/j100083a006
日期:1994.8
A series of substituted phenyl-7'-apocarotenoids with varying electron donating and accepting substituents was examined by cyclic voltammogram (CV) and simultaneous electrochemical electron paramagnetic resonance (SEEPR). Carotenoids substituted with electron donating groups are more easily oxidized than those with electron accepting substituents. Comproportionation constants for the dication and the neutral species were measured by SEEPR techniques and by simulation of the CVs. The Delta H-pp of the SEEPR spectrum of the cation radicals varies from 13.2 to 15.6 G, and the g factors are 2.0027 +/- 0.0002. These EPR parameters suggest a polyene pi-cation radical structure. The CVs are calculated using DigiSim, a CV simulation program, and the proposed mechanism involves three electrode reactions and two homogeneous reactions.
ACTIVATABLE PHOTODYNAMIC THERAPY AGENTS
申请人:Zheng Gang
公开号:US20080193431A1
公开(公告)日:2008-08-14
The present invention relates to the field of conjugates comprising a substrate which is attached to at least one photoactivatable killing agent and at least one first quencher, and methods for their use. More particularly, the present invention relates to photodynamic therapy agents. The invention further relates to methods for decontaminating blood and methods for treating cancer or viral infection in a subject using the conjugates of the present invention.